Comparison of assessment techniques: Plasma lipid and lipoproteins related to the metabolic syndrome

Lipids in Health and Disease

Volumn 5, Issue , 2006, Pages 1-5

  Davy, Brenda M ^a   Davy, Kevin P ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHENOTYPE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33646267183     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-5-1     Document Type: Article

References (18)

1. Lorenzo C, Okoloise M, Williams K, Stern M, Haffner S: The metabolic syndrome as predictor of type 2 diabetes. Diab Care 2003, 26:3153-3159.
2. Malik S, Wong N, Franklin S, Kamath T, L'Italien G, Pio J, Williams R: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110:1245-1250.
3. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults. JAMA 2002, 287(3):356-359.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497.
5. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais G, Lupien P, Despres JP: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997, 95:69-75.
6. Kwiterovich P: HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. Clin Chem 1988, 34(8):B71-B77.
7. Friedlander Y, Kidron M, Caslake M, Lamb T, McConnel M, Bar-On H: Low density lipoprotein particle size and risk factors of insulin resistance syndrome. Atherosclerosis 2000, 148:141-149.
8. Miremadi S, Sniderman A, Frohlich J: Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders? Clin Chem 2002, 48(3):484-488.
9. Sniderman AD, Pedersen T, Kjekshus J: Putting low-density lipoproteins at center stage in atherogenesis. Am J Cardiol 1997, 79:64-67.
10. Demacker PNM, Veerkamp MJ, Bredit SJH, marcovina SM, de Graaf J, Stalenhoef AFH: Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. Atherosclerosis 2000, 153:483-490.
11. Otvos JD: Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. In Handbook of Lipoprotein Testing 2nd edition. Edited by: Rifai N, Warnick G, Dominiczk M. Washington, DC: American Association of Clinical Chemistry; 2000:609-623.
12. Personal communication, Berkeley HeartLab, Inc. .
13. Berkeley HeartLabs, Inc [http://www.bhlinc.com]
14. LipoScience, Inc [http://www.liposcience.com]
15. Blake GJ, Otvos JD, Rifai N, Ridker PM: Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 2002, 106:1930-1937.
16. Haffner S, Williams K, Festa A, Hanley A: LDL particles, small LDL particles, and LDL size by nuclear magnetic resonance spectroscopy are more related to metabolic syndrome components than are apoB and LDL size by gradient gel electrophoresis [abstract]. American Diabetes Association 2005 [http://scientificsessions.diabetes.org/Abstracts].
17. Krauss R: Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr 2001, 131:340S-343S.
18. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982, 23:97-104.